Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC7 | O00311 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.41 |
| ▸ | DAO | P14920 | 1/20 | 0.39 |
| ▸ | PARP1 | P09874 | 2/20 | 0.38 |
| ▸ | ATAD2 | Q6PL18 | 2/20 | 0.38 |
| ▸ | BRD4 | O60885 | 5/20 | 0.37 |
| ▸ | BRD9 | Q9H8M2 | 1/20 | 0.36 |
| ▸ | PARP15 | Q460N3 | 1/20 | 0.35 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.34 |
| ▸ | CCNC | P24863 | 1/20 | 0.33 |
| ▸ | CDK8 | P49336 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | BRPF1 | P55201 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL480033 | 0.82 | NOTUM (0.63) | ALDH1A1NOTUMDAOATAD2BRD4 | |
| SCHEMBL16168454 | 0.79 | — | — | |
| SCHEMBL18696150 | 0.78 | CDC7 (0.43) | CDC7ALDH1A1NOTUMPARP1SMN1; SMN2 | |
| SCHEMBL31337488 | 0.77 | POLB (0.45) | ALDH1A1NOTUMPARP1BRD4KDM4E | |
| SCHEMBL20661372 | 0.74 | ALDH1A1 (0.49) | ALDH1A1BRD4KMT2AKDM4EHSD17B10 | |
| SCHEMBL18584634 | 0.73 | BRD4 (0.43) | CDC7ALDH1A1BRD4HTTKMT2A | |
| SCHEMBL31702852 | 0.73 | CDC7 (0.37) | CDC7ALDH1A1NOTUMDAOPARP1 | |
| Hydrochloric Acid SCHEMBL18584527 | 0.72 | BRD4 (0.42) | CDC7ALDH1A1BRD4HTTKMT2A | |
| SCHEMBL31702823 | 0.72 | CDC7 (0.36) | CDC7ALDH1A1NOTUMDAOMAPK14 | |
| SCHEMBL18584787 | 0.72 | CDC7 (0.36) | CDC7ALDH1A1NOTUMDAOPARP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230243752-A1 | SYSTEM AND METHOD FOR MONITORING THE HEALTH OF DIALYSIS PATIENTS | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. | 2023-08-03 | — | — | US | claimed |
| EP-3151665-A1 | METHODS AND SYSTEMS FOR DETERMINING AUTISM SPECTRUM DISORDER RISK | Laboratory Corporation of America Holdings (US) | 2017-04-12 | — | — | EP | claimed |
| US-20170045455-A1 | SYSTEM AND METHOD FOR MONITORING THE HEALTH OF DIALYSIS PATIENTS | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) | 2017-02-16 | — | — | US | claimed |
| WO-2015164620-A1 | SYSTEM AND METHOD FOR MONITORING THE HEALTH OF DIALYSIS PATIENTS | ROBERTSON JOHN L (US) | 2015-10-29 | — | — | WO | claimed |
| WO-2015157601-A1 | METHODS AND SYSTEMS FOR DETERMINING AUTISM SPECTRUM DISORDER RISK | SYNAPDX CORPORATION (US) | 2015-10-15 | — | — | WO | claimed |
| WO-2014004539-A1 | METABOLOMICS IN PNEUMONIA AND SEPSIS | UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2014-01-03 | — | — | WO | claimed |
| WO-2006024545-A1 | FUSED BICYCLIC NATURAL COMPOUNDS AND THEIR USE AS INHIBITORS OF PARP AND PARP-MEDIATED INFLAMMATORY PROCESSES | STICHTING VOOR DE TECHNISCHE WETENSCHAPPEN (NL) | 2006-03-09 | — | — | WO | claimed |
| CN-115803024-B | Compositions comprising aryl amide derivatives | 中外制药株式会社 | 2025-01-10 | — | — | CN | disclosed |
| CN-114929669-B | Aryl amide derivatives with antitumor activity | 中外制药株式会社 | 2024-11-29 | — | — | CN | disclosed |
| WO-2024086312-A1 | ENHANCED NAD+ COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | BIONADRX HOLDINGS, INC. DBA BRYLEOS (US) | 2024-04-25 | — | — | WO | disclosed |
| EP-4243822-A1 | USE OF PHARMACEUTICAL DOSES OF NIACIN, OR AN ANALOG THEREOF, FOR THE REGRESSION OR REVERSAL OF FIBROSIS AND/OR LIVER CIRRHOSIS | The Regents of The University of California (US) | 2023-09-20 | — | — | EP | disclosed |
| US-20230243752-A1 | SYSTEM AND METHOD FOR MONITORING THE HEALTH OF DIALYSIS PATIENTS | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. | 2023-08-03 | — | — | US | disclosed |
| US-11674903-B2 | System and method for monitoring the health of dialysis patients | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) | 2023-06-13 | — | — | US | disclosed |
| US-20170045455-A1 | SYSTEM AND METHOD FOR MONITORING THE HEALTH OF DIALYSIS PATIENTS | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) | 2017-02-16 | — | — | US | disclosed |
| WO-2015164620-A1 | SYSTEM AND METHOD FOR MONITORING THE HEALTH OF DIALYSIS PATIENTS | ROBERTSON JOHN L (US) | 2015-10-29 | — | — | WO | disclosed |
| WO-2015157601-A1 | METHODS AND SYSTEMS FOR DETERMINING AUTISM SPECTRUM DISORDER RISK | SYNAPDX CORPORATION (US) | 2015-10-15 | — | — | WO | disclosed |
| US-20130309697-A1 | BIOMARKERS FOR PROSTATE CANCER AND METHODS USING THE SAME | MITCHELL MATTHEW W (US) | 2013-11-21 | — | — | US | disclosed |
| US-8518650-B2 | Biomarkers for prostate cancer and methods using the same | METABOLON, INC. (US) | 2013-08-27 | — | — | US | disclosed |
| WO-2011010104-A1 | METHODS | IMPERIAL INNOVATIONS LIMITED (GB) | 2011-01-27 | — | — | WO | disclosed |
| US-20100292331-A1 | Biomarkers for Prostate Cancer and Methods Using the Same | METABALON, INC. (US) | 2010-11-18 | — | — | US | disclosed |